{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:16:16Z","timestamp":1790709376406,"version":"4.1.0"},"reference-count":31,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"Korean Health 21 R&D Project, Ministry of Health, Welfare and Family Affairs","award":["A030001"],"award-info":[{"award-number":["A030001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.2217\/pgs.10.54","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T09:10:38Z","timestamp":1274951438000},"page":"879-884","source":"Crossref","is-referenced-by-count":96,"title":["<i>HLA-B*5901<\/i>\n            is Strongly Associated with Methazolamide-Induced Stevens\u2013Johnson Syndrome\/Toxic Epidermal Necrolysis"],"prefix":"10.1080","volume":"11","author":[{"given":"Sae-Hoon","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea"},{"name":"Institute of Allergy &amp; Clinical Immunology, Seoul National University College of Medicine, Seoul, South Korea"},{"name":"Department of Internal Medicine, Seoul National University, Bundang Hospital, Seongnam, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myunghwa","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Dankook University College of Medicine, Cheonan, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Wha","family":"Lee","sequence":"additional","affiliation":[{"name":"Hallym Institute for Genome Application, Hallym University, Anyang, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Heon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Ryun","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea"},{"name":"Institute of Allergy &amp; Clinical Immunology, Seoul National University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heung-Woo","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea"},{"name":"Institute of Allergy &amp; Clinical Immunology, Seoul National University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Koo","family":"Jee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dankook University College of Medicine, Cheonan, South Korea. Tel.:  Fax:"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2010,5,27]]},"reference":[{"key":"e_1_3_3_3_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(95)30810-X"},{"key":"e_1_3_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1997.01100150552021"},{"key":"e_1_3_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311906"},{"key":"e_1_3_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.1.117"},{"issue":"2","key":"e_1_3_3_3_5_1","first-page":"613","article-title":"Three cases of Stevens\u2013Johnson syndrome associated with methazolamide treatment.","volume":"40","author":"Park YJ","year":"1999","unstructured":"Park YJ , MoonJI, ParkCK: Three cases of Stevens\u2013Johnson syndrome associated with methazolamide treatment.J. Korean Ophthalmol. Soc.40(2) , 613\u2013618 (1999).","journal-title":"J. Korean Ophthalmol. Soc."},{"issue":"10","key":"e_1_3_3_3_6_1","first-page":"2241","article-title":"Association of HLA type with Stevens\u2013Johnson syndrome induced by methazolamide treatment.","volume":"41","author":"Moon JI","year":"2000","unstructured":"Moon JI , SeoJH, ParkCK: Association of HLA type with Stevens\u2013Johnson syndrome induced by methazolamide treatment.J. Korean Ophthalmol. Soc.41(10) , 2241\u20132246 (2000).","journal-title":"J. Korean Ophthalmol. Soc."},{"issue":"6","key":"e_1_3_3_3_7_1","first-page":"798","article-title":"Four cases of Stevens\u2013Johnson syndrome associated with methazolamide treatment.","volume":"38","author":"Ahn EY","year":"2000","unstructured":"Ahn EY , LeeJB, LeeSC, WonYH: Four cases of Stevens\u2013Johnson syndrome associated with methazolamide treatment.Korean Dermatol.38(6) , 798\u2013801 (2000).","journal-title":"Korean Dermatol."},{"issue":"4","key":"e_1_3_3_3_8_1","first-page":"561","article-title":"Two cases of HLA-B59(+) Stevens\u2013Johnson syndrome (SJS)\u2013toxic epidermal necrolysis (TEN) associated with methazolamide treatment.","volume":"43","author":"Sung KH","year":"2005","unstructured":"Sung KH , JwongY, ChoiHU, LeeSK: Two cases of HLA-B59(+) Stevens\u2013Johnson syndrome (SJS)\u2013toxic epidermal necrolysis (TEN) associated with methazolamide treatment.Korean Dermatol.43(4) , 561\u2013563 (2005).","journal-title":"Korean Dermatol."},{"key":"e_1_3_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2005.00386.x"},{"key":"e_1_3_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.2000.560606.x"},{"key":"e_1_3_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12388434"},{"key":"e_1_3_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.3341\/jkos.2009.50.12.1881"},{"key":"e_1_3_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.3.1215"},{"key":"e_1_3_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.9"},{"key":"e_1_3_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.06.004"},{"key":"e_1_3_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj080103"},{"key":"e_1_3_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e3282370c5f"},{"issue":"2","key":"e_1_3_3_3_18_1","first-page":"55","article-title":"Clinical use of pharmacogenomic tests in 2009.","volume":"30","author":"Sheffield LJ","year":"2009","unstructured":"Sheffield LJ , PhillimoreHE: Clinical use of pharmacogenomic tests in 2009.Clin. Biochem. Rev.30(2) , 55\u201365 (2009).","journal-title":"Clin. Biochem. Rev."},{"key":"e_1_3_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/428486a"},{"key":"e_1_3_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.7.6.813"},{"key":"e_1_3_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.11.1617"},{"issue":"1","key":"e_1_3_3_3_22_1","first-page":"216","article-title":"A case of Stevens\u2013Johnson syndrome after acetazolamide use.","volume":"39","author":"Lee JH","year":"1998","unstructured":"Lee JH , LeeSJ, KimYH: A case of Stevens\u2013Johnson syndrome after acetazolamide use.J. Korean Ophthalmol. Soc.39(1) , 216\u2013220 (1998).","journal-title":"J. Korean Ophthalmol. Soc."},{"issue":"2","key":"e_1_3_3_3_23_1","first-page":"248","article-title":"A case of Stevens\u2013Johnson syndrome caused by acetazolamide.","volume":"41","author":"Ha JH","year":"2003","unstructured":"Ha JH , SongJY, KimHO, KimJW: A case of Stevens\u2013Johnson syndrome caused by acetazolamide.Korean J. Dermatol.41(2) , 248\u2013250 (2003).","journal-title":"Korean J. Dermatol."},{"key":"e_1_3_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2009.00646.x"},{"key":"e_1_3_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2008.20.4.260"},{"key":"e_1_3_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1987.01660330082014"},{"key":"e_1_3_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3282f3ef9c"},{"key":"e_1_3_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2004.03.011"},{"key":"e_1_3_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.9.856.36106"},{"key":"e_1_3_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3280109479"},{"key":"e_1_3_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-1549(03)00071-3"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs.10.54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T16:24:03Z","timestamp":1715963043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs.10.54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,27]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.2217\/pgs.10.54"],"URL":"https:\/\/doi.org\/10.2217\/pgs.10.54","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,27]]}}}